Page last updated: 2024-12-08

maltoheptaose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

maltoheptaose: consists of seven glucose residues in a linear 1,4-alpha-linkage; substrate for determining alpha-amylase in serum; RN given refers to (D-glucopyranose)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

maltoheptaose : A maltoheptaose heptasaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp : A maltoheptaose heptasaccharide consisting of six alpha-D-glucose residues and a D-glucose residue joined in sequence by (1->4) glycosidic bonds. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID13908996
CHEMBL ID3322298
CHEBI ID143183
MeSH IDM0098069

Synonyms (17)

Synonym
maltoheptaose
34620-78-5
CHEBI:143183
wurcs=2.0/2,7,6/[a2122h-1x_1-5][a2122h-1a_1-5]/1-2-2-2-2-2-2/a4-b1_b4-c1_c4-d1_d4-e1_e4-f1_f4-g1
alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-alpha-d-glcp-(1->4)-d-glcp
alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-alpha-d-glucopyranosyl-(1->4)-d-glucopyranose
glc(a1-4)glc(a1-4)glc(a1-4)glc(a1-4)glc(a1-4)glc(a1-4)glc
d-maltoheptaose
2-[6-[6-[6-[6-[4,5-dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihyd
CHEMBL3322298 ,
AC-34526
mfcd00064605
bdbm50056222
maltoheptaose, >=60% (hplc)
BNABBHGYYMZMOA-QJBBZCPBSA-N
3,4-(dibenzyloxy)phenethylaminehydrochloride
H10555
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
maltoheptaose heptasaccharideA heptasaccharide comprised of seven D-glucose residues connected by alpha(1->4) linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glycogen phosphorylase, muscle formHomo sapiens (human)Ki1,000.00000.00403.43475.2000AID1186738
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
glycogen metabolic processGlycogen phosphorylase, muscle formHomo sapiens (human)
glycogen catabolic processGlycogen phosphorylase, muscle formHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
nucleotide bindingGlycogen phosphorylase, muscle formHomo sapiens (human)
protein bindingGlycogen phosphorylase, muscle formHomo sapiens (human)
glycogen phosphorylase activityGlycogen phosphorylase, muscle formHomo sapiens (human)
linear malto-oligosaccharide phosphorylase activityGlycogen phosphorylase, muscle formHomo sapiens (human)
SHG alpha-glucan phosphorylase activityGlycogen phosphorylase, muscle formHomo sapiens (human)
pyridoxal phosphate bindingGlycogen phosphorylase, muscle formHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytosolGlycogen phosphorylase, muscle formHomo sapiens (human)
extracellular exosomeGlycogen phosphorylase, muscle formHomo sapiens (human)
cytoplasmGlycogen phosphorylase, muscle formHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1186738Inhibition of glycogen phosphorylase b (unknown origin)2014Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17
Structure based inhibitor design targeting glycogen phosphorylase B. Virtual screening, synthesis, biochemical and biological assessment of novel N-acyl-β-d-glucopyranosylamines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (111)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (5.41)18.7374
1990's21 (18.92)18.2507
2000's44 (39.64)29.6817
2010's33 (29.73)24.3611
2020's7 (6.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other114 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]